PRN Meeting: April 14, 2021 Jointly provided by the Medical Society of the State of New York, at a Zoom webinar, 7:00 p.m. to 9:00 p.m (EST).

Target Audience:

Physicians, Nurse Practitioners, and Physician Assistants caring for people at risk for, or infected with HIV and/or viral hepatitis.

Course Director: James F. Braun, DO, President, Physicians' Research Network

Moderator: William M. Valenti, MD, Chair, Infectious Diseases Committee of the Medical Society of the State of New York

Guest Speakers and Presentations:

HIV and COVID-19 in New York City: A Population-level Analysis

Sarah L. Braunstein, PhD, MPH

Acting Assistant Commissioner, Bureau of HIV
Director, HIV Epidemiology Program
Surveillance and Epidemiology Branch, COVID-19 response
New York City Department of Health and Mental Hygiene

Learning Objectives:

At the completion of this educational session, participants will:
1. Understand the foundations of HIV surveillance and the status of the HIV epidemic in New York City.
2. Learn about the intersection between HIV and COVID-19 in the New York City population.
3. Understand the growing evidence base related to higher risk for adverse COVID-19-related outcomes among people with HIV.

HIV R4P 2021: Updates on the HIV Pre-Exposure Prophylaxis Pipeline

Craig W. Hendrix, MD

Wellcome Professor and Director
Division of Clinical Pharmacology
Departments of Medicine and Pharmacology and Molecular Sciences
Johns Hopkins University School of Medicine, Baltimore, MD

Learning Objectives:

At the completion of this educational session, participants will:
1. Describe the benefits of PrEP choices for global HIV prevention.
2. Understand the limitations of systemic, long-acting PrEP.
3. Discuss ongoing development of on-demand PrEP.
4. Discuss ongoing development of multi-purpose prevention technologies (MPTs).

 

Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). The Medical Society of the State of New York (MSSNY) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing Medical Education for physicians.

The Medical Society of the State of New York (MSSNY) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:

Dr. Braun (Planner/Course Director) has no relevant financial relationships to disclose. Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose. Dr. Sarah L. Braunstein (Presenter) has no relevant financial relationships to disclose. Dr. Braunstein will support her presentation and clinical recommendations with the best available evidence from the medical literature and will submit her slides in advance for adequate peer review. Dr. Craig W. Hendrix (Presenter) has had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Dr. Craig W. Hendrix (Presenter) has had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Research Funding: Gates, ViiV/GSK, Merck, Gilead managed by Johns Hopkins University; Advisory Boards: Population Council, RTI, PREVENT Program, Gilead, Merck, ViiV/GSK, Orion Biopharma; Founder/Officer of Prionde Biopharm. Dr. Hendrix will support his presentation and clinical recommendations with the best available evidence from the medical literature and will submit his slides in advance for adequate peer review.

Financial Support:

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare